Red Queen Bio, a spin-off from the mRNA therapy firm Helix Nano, has successfully closed a $15 million seed funding round, with OpenAI taking the lead. The startup is dedicated to averting the creation of biological weapons driven by AI, making sure that as AI defense capabilities advance, so too does the ability to thwart malicious exploitation.
